Replies to post #803052 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

What kind of results can you expect on Survaxm? I can tell there is only one result pending for Survaxm: Failure. What is the target Survaxm chose? Is it survivin?

If you read Dr. Liau's papers, you should know that Dr. Liau conducted a trial by loading DCs with peptides derived from antigens TRP-2, gp100, her-2/neu, and survivin. The trial results cannot outperform those from the approach which adopted tumor-lysate. Clearly, Survaxm cannot beat DCVax-L.

Even though I suspect the trial will to fail to show an OS improvement between the randomized arms, I think it is very likely the MOS will beet DC-L. Alas, I think the randomized control arm will easily beat NWBO's ECA numbers.

Hopefully we will see. But as MimiVax is private they might well disclose little to nothing.